ESC 365 - Unrealized opportunities for cardiovascular risk reduction with optimized statin and ezetimibe in veterans with coronary artery disease

ESC Professional Premium Access

Unrealized opportunities for cardiovascular risk reduction with optimized statin and ezetimibe in veterans with coronary artery disease

Session: Risk factors and prevention: lipids (5)

Topic: Drug therapy

Speaker: Doctor P. Gupta (Aurora, US)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Prerna Gupta

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

0 follower

8 more presentations in this session

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

L-shaped association of lipoprotein(a) on long-term bleeding risk in patients with coronary heart disease: insight from a multicenter cohort in Asia

Speaker: Doctor P. Wang (Beijing, CN)

Survey on lipid management in cardiovascular primary prevention: do physicians follow the guidelines?

Speaker: Professor M. Alami (Casablanca, MA)

Remnant cholesterol predicts major cardiovascular events in cardiovascular disease patients with NAFLD

Speaker: Doctor B. Larcher (Feldkirch, AT)

Access the full session

Risk factors and prevention: lipids (5)

Speakers: Doctor P. Gupta, Doctor H. Tada, Doctor H. Tada, Doctor P. Wang, Professor M. Alami...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources